Rice Hall James & Associates LLC Takes Position in Varex Imaging $VREX

Rice Hall James & Associates LLC purchased a new stake in Varex Imaging (NASDAQ:VREX) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,445,853 shares of the company’s stock, valued at approximately $15,080,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. acquired a new position in Varex Imaging during the fourth quarter worth $27,000. Quarry LP acquired a new stake in shares of Varex Imaging in the 3rd quarter worth $64,000. BNP Paribas Financial Markets increased its stake in shares of Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after acquiring an additional 2,036 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in shares of Varex Imaging during the 3rd quarter worth $117,000. Finally, Cerity Partners LLC purchased a new position in shares of Varex Imaging during the 2nd quarter worth $123,000.

Varex Imaging Price Performance

NASDAQ:VREX opened at $18.46 on Tuesday. Varex Imaging has a 52 week low of $9.09 and a 52 week high of $18.63. The stock’s fifty day moving average is $11.77 and its two-hundred day moving average is $11.70. The company has a market capitalization of $777.17 million, a P/E ratio of 35.50 and a beta of 0.89. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings results on Monday, August 10th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The business had revenue of $210.50 million during the quarter, compared to analysts’ expectations of $215.50 million. Varex Imaging had a return on equity of 9.19% and a net margin of 2.55%. Equities analysts expect that Varex Imaging will post 0.93 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on VREX shares. Zacks Research cut shares of Varex Imaging from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 27th. CJS Securities cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday. B. Riley Financial downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. Sidoti reiterated a “neutral” rating and issued a $19.00 target price on shares of Varex Imaging in a report on Monday, August 10th. Finally, Oppenheimer cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. Six equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $16.88.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.